The regulatory requirements in emerging CEE markets remain challenging for the pharmaceutical and medical device manufacturers alike. Slovakia has earned the reputation of a country with the advanced regulatory environment and well-developed operating systems. As a testimony, Bratislava emerged as a strong candidate in the race to host the headquarters of the European Medicines Agency…
Pharma Regulatory Professionals Meeting will take place in Prague on October 24-26, 2017 at Clarion Congress Hotel Read more
Estonian annual drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. WHOLESALERS In January 2017 there were 64 wholesalers in Estonia and six of them were specialized only on veterinary medicines. 2013 2014 2015 2016…
According to analysts with QuintilesIMS, Poland’s pharmaceutical market will be worth PLN 38.5 billion (EUR 9 bn) by the end of 2017, which marks a 5.4-percent hike year on year. The growing figures are largely determined by an uptick in demand for medicine available over the counter, the authors of the report said. This sector…
The Ministry of Health in Kazakhstan is introducing changes to the existing legislation for distribution of pharmaceutical products and medical devices with the view to improve regulation of prices and ‘create a patient-oriented drug provision model. According to a new draft law, in October 2018 regulated prices will be introduced for all prescription pharmaceutical products…
The healthcare spending in Poland has been steadily on the rise over the last 3 years. In 2016, the budget of the National Health Fund (NFZ) grew by 3.8% with 4.8% increase expected in 2017. The Polish government is determined to boost the 2018 NFZ budget by PLN5.5bn which would result in a total healthcare…